CVE:MJN - Cronos Group Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseC$12.38
Today's RangeC$11.90 - C$12.47
52-Week RangeC$1.58 - C$12.47
Volume1.39 million shs
Average Volume2.07 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Cronos Group Inc, formerly PharmaCan Capital Corp, is a Canada-based cannabis company. The Company operates two Licensed Producers (LPs) regulated within Health Canada's Access to Cannabis for Medical Purposes Regulations (the ACMPR) and holds a portfolio of investments in other Licensed Producers and ACMPR applicants. Its LPs, Peace Naturals Project Inc. and In The Zone Produce Ltd., are collectively located on over 125 acres of agricultural land. It also holds equity positions in Licensed Producers Whistler Medical Marijuana, Hydropothecary and Abcann Medicinals. Whistler Medical Marijuana is licensed to produce and sell medical marijuana, as well as cultivate cannabis oil. Hydropothecary is licensed to produce medical marijuana. Abcann Medicinals also has license to produce medical marijuana. With interest in five Licensed Producers and two LP applicants, it is focused on building brand portfolio providing patients with personalized care.

Receive MJN News and Ratings via Email

Sign-up to receive the latest news and ratings for MJN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryCannabis
SectorN/A
CUSIPN/A
CIKN/A
Phone+1-416-5040004

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableOptionable

Cronos Group (CVE:MJN) Frequently Asked Questions

What is Cronos Group's stock symbol?

Cronos Group trades on the Canadian Venture Exchange (CVE) under the ticker symbol "MJN."

Has Cronos Group been receiving favorable news coverage?

Media stories about MJN stock have trended somewhat positive this week, according to InfoTrie. The research firm ranks the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Cronos Group earned a news sentiment score of 1.0 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the next few days.

What other stocks do shareholders of Cronos Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Cronos Group (CRON), Aurora Cannabis (ACB), Canopy Growth (CGC), Canopy Growth (WEED), Aphria (APHA), OrganiGram (OGI), IMV (IMV), Hydropothecary (THCX), Aurora Cannabis (ACBFF) and CanniMed (CMED).

Who are Cronos Group's key executives?

Cronos Group's management team includes the folowing people:
  • Michael Ryan Gorenstein, President, Chief Executive Officer, Vice Chairman of the Board, Corporate Secretary
  • William Lawrence Hilson, Chief Financial Officer
  • Jason Adler, Director
  • Ryan Roebuck, Director
  • James Rudyk, Director
  • Alan Mark Friedman, Independent Director (Age 45)
  • Michael Howard Krestell, Independent Director

How do I buy shares of Cronos Group?

Shares of MJN and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Cronos Group's official website?

The official website for Cronos Group is http://thecronosgroup.com/.

How can I contact Cronos Group?

Cronos Group's mailing address is 720 King St W Suite 320, TORONTO, ON M5V 2T3, Canada. The company can be reached via phone at +1-416-5040004.


MarketBeat Community Rating for Cronos Group (CVE MJN)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  114 (Vote Outperform)
Underperform Votes:  107 (Vote Underperform)
Total Votes:  221
MarketBeat's community ratings are surveys of what our community members think about Cronos Group and other stocks. Vote "Outperform" if you believe MJN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MJN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 5/24/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel